EP 0716703 A1 19960619 - GLYCOPHORIN BINDING PROTEIN (GBP130) FUSION COMPOSITIONS
Title (en)
GLYCOPHORIN BINDING PROTEIN (GBP130) FUSION COMPOSITIONS
Title (de)
GLYCOPHORIN BINDENDE PROTEINE (GBP130) FUSIONSZUSAMMENSETZUNGEN
Title (fr)
COMPOSITIONS PROTEIQUES DE FUSION CONTENANT LA PROTEINE DE LIAISON A LA GLYCOPHORINE (GBP 130)
Publication
Application
Priority
- GB 9401900 W 19940901
- GB 9318350 A 19930903
- GB 9417021 A 19940823
Abstract (en)
[origin: WO9506737A1] Hybrid or fusion peptides formed by the fusion of two or more peptide components, where one component is derived from or is all or part of a malaria parasite red blood cell binding peptide, and the other peptide being a receptor for or capable of binding to a cytokine or other mediator of inflammation or immunity. The fusion peptides find a use in the treatment of septic shock, AIDS, and inflammatory conditions. The fusion peptides also serve as potential testing agents for use in inflammatory conditions and septic shock.
IPC 1-7
IPC 8 full level
C07K 14/445 (2006.01); C07K 14/715 (2006.01)
CPC (source: EP)
C07K 14/445 (2013.01); C07K 14/715 (2013.01); C07K 2319/00 (2013.01); Y02A 50/30 (2017.12)
Citation (search report)
See references of WO 9506737A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE
DOCDB simple family (publication)
DOCDB simple family (application)
GB 9401900 W 19940901; EP 94924961 A 19940901